Page 1 - hypertension_newsletter (5)

REFLECTIONS rtensio n
Hype
Hypertension Global Newsletter #2 Hype n oisnetr

TABLE OF CONTENTS On behalf of the Scientific Planning Committee, I would like to
welcome you back to the second newsletter in our series where
KEY ARTICLES we summarize the latest clinical and real-world evidence in the
field of hypertension and reflect on the clinical impact of these
EPIDEMIOLOGY data on the management of patients with hypertension. This
time we will focus on 1) epidemiology, 2) hypertension-mediated
Home blood pressure monitoring: Methodology, organ damage and arterial stiffness, and 3) adherence issues.
clinical relevance and practical application: A 2021 As with the previous installment, we invite you to interact with
position paper by the Working Group on Blood this newsletter through links to view short clinical perspectives
Pressure Monitoring and Cardiovascular Variability from our SPC and delve into the articles through hyperlinks for
of the European Society of Hypertension. Parati G, et in-depth study.
al. J Hypertens. 2021;39(9):1742-1767.
Prof. Laurent (Chair)
European Society of Hypertension position paper
on renal denervation 2021. Schmieder RE, et al. J SCIENTIFIC PLANNING COMMITTEE
Hypertension. 2021;39(9):1733-1741.
Prof. Stéphane Prof. Adriana Camargo
HYPERTENSION-MEDIATED ORGAN DAMAGE/ Laurent (Brazil)
ARTERIAL STIFFNESS (France)

Hypertension-mediated organ damage: Prevalence, Prof. Adolfo Chavez Prof. Wei Sun
correlates, and prognosis in the Community. Vasan (Mexico) (China)
RS, et al. Hypertension. 2022;79(3):505-515.
Prof. Nqoba Tsabedze Prof. Svetlana Villevalde
The SPARTE Study: Normalization of arterial (South Africa) (Russia)
stiffness and cardiovascular events in patients with
hypertension at medium to very high risk. Laurent S,
et al. Hypertension. 2021;78(4):983-995.

ADHERENCE

Adherence to single-pill versus free-equivalent
combination therapy in hypertension: A systematic
review and meta-analysis. Parati G, et al. Hypertension.
2021;77(2):692-705.

Nonadherence in hypertension: How to develop and
implement chemical adherence testing. Lane D, et al.
Hypertension. 2022;79(1):12-23.

ADDITIONAL ARTICLES OF INTEREST

EPIDEMIOLOGY

Home blood pressure monitoring: Methodology, clinical relevance and practical
application: A 2021 position paper by the Working Group on Blood Pressure
Monitoring and Cardiovascular Variability of the European Society of Hypertension.

Parati G, et al. J Hypertens. 2021;39(9):1742-1767.

Arterial hypertension is a key CV risk factor and is closely associated with mortality and morbidity globally. The current suboptimal
management of hypertension may be in part due to the limitations of using only office BP (OBP) measurements. Alternatives to OBP
include ambulatory BP monitoring (ABPM) and home BP monitoring (HBPM). Adoption of HBPM has grown exponentially with the
availability of small, accurate, user-friendly, and relatively inexpensive BP monitoring devices. This position paper is an update on
previous recommendations from the ESH Working Group on BP Monitoring and Cardiovascular Variability.